Skip to content

Dazzle Healthcare

Home / GENERAL RANGE / RETRADAZ-200

Awaiting product image

RETRADAZ-200

₹1,600.00

RETRADAZ-200 quantity

SKU: cabeb44b98e3 Category: GENERAL RANGE

Description
Additional information

Description

Rifaximin 200 mg tab

Additional information

PACKING	10×10(Alu-Alu)
MRP	1600

Related products

DENGUDIX
₹2,550.00 Add to basket
AMLOCRED-AT
₹480.00 Add to basket
DAZCET-AM
₹650.00 Add to basket
CINDAZ-25
₹300.00 Add to basket

Search

Recent Posts

Top 10 PCD Pharma Franchise Companies in India: Compare Products, Certifications & Business Opportunities Guide
Top PCD Pharma Franchise Company in Haryana: A Practical Guide for Pharma Entrepreneurs
PCD Pharma Franchise in Andhra Pradesh: A Growing Business Opportunity with Dazzle Healthcare
PCD Pharma Franchise in Uttar Pradesh: The Complete 2026 Guide
Dazcef-S 1500 Injection: Uses, Benefits, Composition, and Market Potential

Recent Comments

No comments to show.

Archives

September 2026
August 2026
July 2026
June 2026
May 2026
April 2026
March 2026
February 2026
January 2026
December 2025
October 2025
September 2025
August 2025
July 2025
June 2025
May 2025

Categories

Blogs

Quick Enquiry

Error: Contact form not found.

Recent Blogs

Top 10 PCD Pharma Franchise Companies in India: Compare Products, Certifications & Business Opportunities Guide
Top PCD Pharma Franchise Company in Haryana: A Practical Guide for Pharma Entrepreneurs
PCD Pharma Franchise in Andhra Pradesh: A Growing Business Opportunity with Dazzle Healthcare
PCD Pharma Franchise in Uttar Pradesh: The Complete 2026 Guide
Dazcef-S 1500 Injection: Uses, Benefits, Composition, and Market Potential
How to Choose the Best PCD Pharma Franchise Company in India (2026 Complete Buyer’s Guide)
PCD Pharma Franchise in Uttar Pradesh – Why Dazzle Healthcare Is the Right Partner in 2026
Top 20 Fast Moving Pharma Products for PCD Franchise

Facebook
Twitter
Instagram
Email

Proudly powered by WordPress.

Leave this field empty

What is $Refresh icon$ $Refreshing captcha$

Solve the math problem shown in the image to continue.